Brochure - University of Ottawa€¦ · Brochure Goal: The goal of this conference is to produce a...
4
2014 EC5 23-25 October 2014 Montreal, Quebec February 4-6, 2016 HÔTEL NELLIGAN Montréal, Québec For further information, please contact: Jody Chaters, Continuing Professional Development Coordinator Division of Medical Oncology, The Ottawa Hospital Cancer Centre Tel: : 613-798-5555 ext 73602 | Fax: 613.247.3511 | Email: [email protected] Eastern Canada Colorectal Cancer Consensus Conference 2016 E 5 C Brochure Goal: The goal of this conference is to produce a consensus opinion produced by oncologists and allied health profes- sionals from across Eastern Canada for the purpose of recommending management strategies for patients with colorectal cancer (CRC) and selected gastrointestinal cancers. The final report will be submitted for publication to “Current Oncology”; a peer reviewed, Canadian based and internationally distributed journal, representing a multi- disciplinary medium, encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Overall learning objectives of this program: At the end of this program learner will be able to: • Describe the optimal treatment of medical, radiation and surgical treatment of Gastrointestinal Cancers. • Summarize the 2014 GI Consensus and WC5. • Explain what happens to the colorectal cancer survivor after treatment. • Interpret optimal management of malignancy in the liver; metastatic and primary and SBRT for oligometastatic disease. Outcome: • Obtain consensus on new or emerging therapies. • Publication in “Current Oncology”. • Discuss standards of care in rectal and Gastro-intestinal cancer. Target Audience From ON, PQ, NB, NS, PEI, NF: • Medical and Radiation Oncologists. • Oncology Surgeons.
Transcript of Brochure - University of Ottawa€¦ · Brochure Goal: The goal of this conference is to produce a...
2014 EC5 23-25 October 2014 Montreal, Quebec
February 4-6, 2016
HÔTEL NELLIGAN
Montréal, Québec
For further information, please contact:
Jody Chaters, Continuing Professional Development Coordinator
Division of Medical Oncology, The Ottawa Hospital Cancer Centre
Tel: : 613-798-5555 ext 73602 | Fax: 613.247.3511 | Email: [email protected]
Eastern
Canada
Colorectal
Cancer
Consensus
Conference 2016
E
5
C
Brochure
Goal: The goal of this conference is to produce a consensus opinion produced by oncologists and allied health profes-sionals from across Eastern Canada for the purpose of recommending management strategies for patients with colorectal cancer (CRC) and selected gastrointestinal cancers. The final report will be submitted for publication to “Current Oncology”; a peer reviewed, Canadian based and internationally distributed journal, representing a multi-disciplinary medium, encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease.
Overall learning objectives of this program: At the end of this program learner will be able to: • Describe the optimal treatment of medical, radiation and surgical treatment of Gastrointestinal Cancers. • Summarize the 2014 GI Consensus and WC5. • Explain what happens to the colorectal cancer survivor after treatment. • Interpret optimal management of malignancy in the liver; metastatic and primary and SBRT for oligometastatic disease.
Outcome: • Obtain consensus on new or emerging therapies. • Publication in “Current Oncology”. • Discuss standards of care in rectal and Gastro-intestinal cancer.
Target Audience From ON, PQ, NB, NS, PEI, NF: • Medical and Radiation Oncologists. • Oncology Surgeons.
19:00-21:00 Registration and Welcome Reception
07:30-07:50 Continental Breakfast & Networking
07:50-08:00 Welcome Dr. Tim Asmis
08:00-08:30
Review of GI Consensus from 2014 • Identify variables in NET pathology report influencing decision making and discussGEP NET treatment options; • Develop a competitive plan for advanced/metastatic pancreatic cancer management;• Describe the role of EGFR inhibitors in the 1st line treatment of metastatic CRC• Apply CRC screening approaches in practice
Dr. Elena Tsvetkova
08:30-09:15
An update on the 2015 WC5 • Identify the goals and framework of the 2015 Western Canadian GI ConsensusMeeting • Summarize the conclusions of the 2015 Western Canadian GI Consensus Meeting
Dr. Sharlene Gill
09:15-10:00 The Trials and Tribulations of Immunotherapy as a Cancer Treatment Dr. Xinni Song
10:00-10:15 Break
10:15-11:00 Survivorship and Follow-up of Patient After Treatment of CRC • Review follow up guidelines for survivors of resected colorectal cancer• Describe the wellness beyond cancer program
Dr. Tim Asmis
11:00-11:45 Prevention of Hepatitis B, HIV, Aids, Hep C and TB TBD
11:45-13:00 Lunch and Networking
13:00-13:45
Neoadjuvant Therapy in Pancreas- Levels of Evidence • Describe the challenges in treating locally advanced pancreatic cancer (LAPC) in thecurative and non-curative settings • Explain current and future treatment algorithms for LAPC• Identify the mechanisms and associated challenges of drug funding for LAPC inCanada
Dr. Jim Biagi
13:45-14:30
Surgical Options in Pancreatic Cancer • Describe the current evidence supporting surgical resection in pancreatic cancer• Explain the evolving criteria of resectable pancreatic cancer• Describe the options for vascular resection in pancreatic cancer• Analyze the current evidence and future directions of pre-operative chemotherapy andradiation in advanced disease.
Dr. Sean Cleary
14:30-14:45 PM break and Networking
14:45-15:30
Role of Radiation in Localized Pancreatic Cancer • Explain the indications and types of transarterial therapies for HCC• Describe the evidence base for transarterial therapies for HCC• Summarize the indications and technical considerations for RFA in the context of HCC• Describe the evidence base for RFA for HCC
Dr. James Brierley
18:30-21:00 Dinner
2016 EC5 Thursday, February 4, 2016
Friday, February 5, 2016
08:00-08:30 Continental Breakfast & Networking
08:30-09:15
Radiation Treatment for HCC and Bile Duct Cancer • Identify the most suitable patients for treatment with stereotactic body radiation therapy (SBRT) or radical radiation therapy (RT) • Demonstrate the potential risks of RT in the treatment of hepatobiliary cancers.• Describe active clinical trials of SBRT and palliative RT for patients with hepatobili-ary cancers
Dr. Laura Dawson
09:15-10:00
Surgical option of Liver Metastic • Identify repectability criteria• Update current status of adjuvant/neoadjuvant therapy in resectable colorectal livermetastases • Review management of synchronous presentation of resectable liver metastasesand colorectal primary • Review emerging new issue related to resectable liver metastases
Dr. Prosanto Chaudhury
10:00-10:15 BREAK
10:15-11:00 Radiation Treatment of Oligometastases • Describe stereotactic body radiotherapy (SBRT)• Define the role of SBRT in the treatment of metastatic patients
Dr. Neil Kopek
11:00-11:45
Focal tumour ablation options for hepatocellular carcinoma • Explain the indications and types of transarterial therapies for HCC• Describe the evidence base for transarterial therapies for HCC• Summarize the indications and technical consideratiJAons for RFA in the context ofHCC • Describe the evidence base for RFA for HCC
Dr. Guillaume Martel
Adjournment
2016 EC5
Friday, February 5, 2016
Dr. Christine Cripps, Chair Medical Oncologist Ottawa Hospital Cancer Centre
Dr. Tim Asmis Medical Oncologist Ottawa Hospital Cancer Centre
Dr. James Biagi Medical Oncologist Cancer Centre of South Eastern Ontario, Kingston
Dr. Bruce Colwell Medical Oncologist QEII Health Sciences Centre
Dr. Conrad Falkson Radiation Oncologist Cancer Centre of South Eastern Ontario, Kingston
Dr. Geoff Porter Surgeon Oncology Dalhousie University and QEII Health Sciences Centre
Dr. Benoit Samson Medical Oncologist Hôpital Charles LeMoyne
Dr. Michael Thirlwell Medical Oncologist Montreal General Hospital
Dr. Michael Vickers Medical Oncologist Ottawa Hospital Cancer Centre
PLANNING COMMITTEE
Thank you to our planning committee for your participation in planning this event
SPONSORS
Thank you to our sponsors for your participation in planning this event
2016 EC5
Hotel Nelligan 106 Saint-Paul Street West, Montreal, QC H2Y 1Z3 CA
Property Location: With a stay at Hotel Nelligan in Montreal (Old Montreal), you'll be minutes from Montreal Museum of Archaeology and History
and Notre Dame Basilica. This 4-star hotel is within close proximity of Place Royale and Old Port.
Rooms: Make yourself at home in one of the 105 rooms featuring iPod docking stations and minibars plus complimentary wireless In-
ternet access. Bathrooms have designer toiletries and hair dryers.
Run of House rate: The group rate of $169.00 + taxes
Reservations must be made before January 14th at 5pm
Reservation requests received after the cut-off date will be based on availability at the hotel’s prevailing rates.
Call: 514.788.2040 or 1.877.788.2040 (Quote: OTT0204_001 or Ottawa Hospital Cancer Centre
Online: Go to: www.hotelnelligan.com Click on “Reserve” Click on “Book Now”
Enter the access code: OTT0204_001
Parking:
Overnight Valet: $28 CAD (plus HST). Includes in/out privileges.
Daily parking: $19 (plus HST) per day. Does not include in/out privileges.
REGISTRATION
Online Registration Available! Please visit: www.eply.com/EC5registration
Fee includes reception February 4, breakfast, lunch and dinner February 5, breakfast February 6 and refreshment breaks
Register online and save $$$ on your total registration.
Registrations will not be processed without full payment.
Refunds less $75.00 administrative charge will be issued for cancellations received on or before Sunday January 24, 2016.
Refunds will not be issued for cancellations received after this date.
Post-dated cheques are not accepted.
The University of Ottawa (U of O) reserves the right to cancel courses. Registrants will be notified at the earliest possible date
Category Earlybird Fee
on or before Jan 9, 2016
Regular Fee
after Jan 10, 2016
Physician $125.00 $150.00
Resident/Fellow $50.00 $50.00
Save by registering online! If you are registering by mail or fax add: $5.00 ( Manual Registration Fee )
Total Fee:
Attending Reception Feb 4? □ Yes □ No Attending Dinner Feb 5? □ Yes □ No
